Aurobindo Pharma Limited: insider trades · India · SEBI (PIT + SAST) SEBI:aurobindo-pharma-limited IN IN · SEBI (PIT + SAST) Mcap 674.0Bn€
Discover the full management transaction log of Aurobindo Pharma Limited, a publicly traded company based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €674bn. The latest transaction was filed on 30 March 2024 — Pledge. Among the most active insiders: RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding). All data is free.
Financial data FY ended March 2025 · cache
Income statement
Revenue 313.78 Bn€
Gross profit 176.37 Bn€ 56% margin
Net income 34.86 Bn€ 11.1% margin
Balance sheet & cash
Market cap 674.02 Bn€
Total debt 82.63 Bn€
Free Cash Flow 14.05 Bn€
Last declaration on 30 March 2024
Declarations 168 total
Executives ● Pledge0 SEBI
€140m 11,635,862 shares @ €12.0742
Equity Shares
SEBI:5e6c283adca6bfea5b27836809cf3ca381b6e7ce · 30 Mar 2024
Executives ● Pledge0 SEBI
€194m 16,700,000 shares @ €11.6351
Equity Shares
SEBI:67aa7b1e0f97fd1e83b4e56721569ec3a273a71f · 26 Mar 2024
Executives ● Sale0 SEBI
€11,364 1,000 shares @ €11.3636
Equity Shares
SEBI:c76bab9f89aadb29f9c0debc58ebc930712be0c7 · 29 Feb 2024
Executives ● Sale0 SEBI
€23,332 2,000 shares @ €11.6658
Equity Shares
SEBI:0a27db88c87689bbf58ab51b2460a877ac39a175 · 23 Feb 2024
Executives ● Pledge0 SEBI
€117m 10,050,000 shares @ €11.6258
Equity Shares
SEBI:ae693db06237826e067fc058b2c1697f6875ea91 · 23 Feb 2024
Executives ● Pledge0 SEBI
€27m 2,300,000 shares @ €11.6258
Equity Shares
SEBI:77b5a7d9adc270e847fb494111cc85be9a56511c · 23 Feb 2024
Executives ● Sale0 SEBI
€397,888 35,000 shares @ €11.3682
Equity Shares
SEBI:84d4ae9eb9a49dffb4b1dedecc6b363b7ad12f93 · 13 Feb 2024
Executives ● Sale0 SEBI
€44,091 3,880 shares @ €11.3637
Equity Shares
SEBI:cdc43a8ac1111e691637677a421b0cc98cee8957 · 14 Feb 2024
Executives ● Sale0 SEBI
€14,362 1,300 shares @ €11.0479
Equity Shares
SEBI:71fa3f75e26e1ed579d9415152bf442871cbb87f · 14 Feb 2024
Executives ● Pledge0 SEBI
€150m 13,400,000 shares @ €11.1952
Equity Shares
SEBI:6fdea43e87a1ce84c066cc2fd65d923d1bc14671 · 14 Feb 2024
Executives ● Sale0 SEBI
€22,958 2,000 shares @ €11.4788
Equity Shares
SEBI:f32b92c21022933d84e32558b34c814148790139 · 13 Feb 2024
Executives ● Pledge0 SEBI
€5m 400,000 shares @ €12.4144
Equity Shares
SEBI:8885e7d92541ff50c64b99164f9c9f5914a3cdb6 · 18 Jan 2024
Executives ● Pledge0 SEBI
€3m 250,000 shares @ €12.323
Equity Shares
SEBI:d39909e7143ecf0c9f2cbcba68b8f240c2bbd3ac · 16 Jan 2024
Executives ● Sale0 SEBI
€11,809 1,000 shares @ €11.809
Equity Shares
SEBI:ac0a8f8a76db047676dd5b8ca1f2b0b5644c24fb · 27 Dec 2023
Executives ● Sale0 SEBI
€11,654 1,000 shares @ €11.6543
Equity Shares
SEBI:c951329bc328c199a1218856efd3887f796545de · 29 Dec 2023
Executives ● Sale0 SEBI
€176,044 15,000 shares @ €11.7363
Equity Shares
SEBI:f86158fa16c626484a9ef5361db80291ce6e7ad4 · 20 Dec 2023
Executives ● Sale0 SEBI
€106,027 9,000 shares @ €11.7808
Equity Shares
SEBI:f0ce706da77de3c47b157ce7a04e0f091a23ac9c · 26 Dec 2023
Executives ● Sale0 SEBI
€47,013 4,000 shares @ €11.7534
Equity Shares
SEBI:16f1920e021956596fbbd3046d12ba17b63250bc · 26 Dec 2023
Executives ● Sale0 SEBI
€29,653 2,500 shares @ €11.8612
Equity Shares
SEBI:12ffb27351ca6b8706ea3f7014d84a0a6b2d31ca · 22 Dec 2023
Executives ● Sale0 SEBI
€17,540 1,500 shares @ €11.6936
Equity Shares
SEBI:97a2e86bb3aacfde85f1f0c7ad30a6c5eebe1b74 · 21 Dec 2023
Executives ● Sale0 SEBI
€40,938 3,500 shares @ €11.6966
Equity Shares
SEBI:4c69fd9b6a247323cfddca168a15740fdb60247f · 20 Dec 2023
Executives ● Sale0 SEBI
€17,151 1,500 shares @ €11.4339
Equity Shares
SEBI:e8b13707769a951413941583412f3610ac113a92 · 20 Dec 2023
Executives ● Sale0 SEBI
€11,304 1,000 shares @ €11.3041
Equity Shares
SEBI:6d45dc43a88b76419c27dea6e1055aed8032cfa4 · 7 Dec 2023
Executives ● Sale0 SEBI
€34,024 3,000 shares @ €11.3415
Equity Shares
SEBI:85fd80c8469e974740bf05287bc279b5a48366cf · 4 Dec 2023
Executives ● Sale0 SEBI
€15,061 1,350 shares @ €11.1564
Equity Shares
SEBI:341d575722aca4b11c47ea3f5cca633fa64cc343 · 29 Nov 2023
25 of 168 declarations
Load more (143 remaining) About Aurobindo Pharma Limited Aurobindo Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.